• Siemens Healthineers fiscal Q3 net income rose 21.7% to €676 million as revenue increased 1.8% to €5.76 billion.
• Adjusted EBIT climbed 15.6% to €1.1 billion; adjusted EBIT margin widened 2.3 percentage points to 19.1%.
• Adjusted basic EPS increased 10% to €0.70, helped by refunds of U.S. IEEPA tariffs.
• Equipment book-to-bill ratio was 1.27; Diagnostics revenue fell 6.3% to €992 million, while Precision Therapy revenue rose 7.9% to €1.75 billion.
• Full-year comparable revenue growth outlook cut to 3.5%-4% from 4.5%-5%, while adjusted basic EPS view lifted to €2.35-€2.45 from €2.20-€2.30.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Siemens Healthineers AG published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.